NEW YORK (GenomeWeb) – Quanterix said after the close of the market today that it raised $49.7 million last week via issue of 2.2 million shares of common stock.
The company sold the shares at an average price of $22.73 per share under a $50 million at-the-market equity facility it filed as part of a shelf registration statement with the US Securities and Exchange Commission in March 2019. It said that it will use the proceeds to fund commercial expansion, particularly in China, to accelerate research and development aimed at boosting its instrument sensitivity, and for new product development and acquisitions.
Quanterix also said that it planned to release its Simoa HD-X analyzer on Wednesday at the BIO International Convention in Philadelphia. The HD-X will replace the company's original HD-1 analyzer.
Quanterix is currently taking orders for the HD-X and plans to begin shipping instruments in Q4 2019.